Sfoglia per Rivista
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials
2023-01-01 Gentile, Massimo; Vigna, Ernesto; Palmieri, Salvatore; Galli, Monica; Derudas, Daniele; Mina, Roberto; Pepa, Roberta Della; Zambello, Renato; Martino, Enrica Antonia; Bruzzese, Antonella; Mangiacavalli, Silvia; Zamagni, Elena; Califano, Catello; Musso, Maurizio; Conticello, Concetta; Cerchione, Claudio; Mele, Giuseppe; Di Renzo, Nicola; Offidani, Massimo; Tarantini, Giuseppe; Casaluci, Gloria Margiotta; Rago, Angela; Ria, Roberto; Uccello, Giuseppina; Barilà, Gregorio; Palumbo, Gaetano; Pompa, Alessandra; Vincelli, Donatella; Brunori, Marino; Accardi, Fabrizio; Amico, Valeria; Amendola, Angela; Fontana, Raffaele; Bongarzoni, Velia; Rossini, Bernardo; Cotzia, Emilia; Gozzetti, Alessandro; Rizzi, Rita; Sgherza, Nicola; Ferretti, Eleonora; Bertuglia, Giuseppe; Nappi, Davide; Petrucci, Maria Teresa; Di Raimondo, Francesco; Neri, Antonino; Morabito, Fortunato; Musto, Pellegrino
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials
2020-01-01 Gentile, M; Specchia, G; Derudas, D; Galli, M; Botta, C; Rocco, S; Conticello, C; Califano, C; Giuliani, N; Mangiacavalli, S; Attingenti, E; Lombardo, A; Brunori, M; Rossi, E; Antonioli, E; Ria, R; Zambello, R; Di Renzo, N; Mele, G; Marcacci, G; Musto, P; Capalbo, S; Cascavilla, N; Cerchione, C; Belotti, A; Criscuolo, C; Uccello, G; Curci, P; Vigna, E; Fraticelli, V; Vincelli, D; Bonalumi, A; Siniscalchi, A; Stocchi, R; Martino, M; Ballanti, S; Gangemi, D; Gagliardi, A; Gamberi, B; Pompa, A; Recchia, Ag; Tripepi, G; Pitino, A; Frigeri, F; Consoli, U; Bringhen, S; Zamagni, E; Patriarca, F; De Stefano, V; Di Raimondo, F; Palmieri, S; Petrucci, Mt; Offidani, M; Boccadoro, M; Cavo, M; Morabito, F.
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
2003-01-01 Mauro, Fr; Zinzani, P; Zaja, F; Gentile, M; Vegna, Ml; Stefoni, V; Marin, L; Fanin, R; Baccarani, M; Tura, S; Mandelli, F.
Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients.
2002-01-01 Mauro, Fr; Foa, R; Meloni, G; Gentile, M; Giammartini, E; Giannarelli, D; De Propris, Ms; Rapanotti, Mc; de Fabritiis, P; Mandelli, F.
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial
2019-01-01 Bringhen, S; D'Agostino, M; Paris, L; Ballanti, S; Pescosta, N; Spada, S; Pezzatti, S; Grasso, M; Rota-Scalabrini, D; De Rosa, L; Pavone, V; Gazzera, G; Aquino, S; Poggiu, M; Santoro, A; Gentile, M; Baldini, L; Petrucci, Mt; Tosi, P; Marasca, R; Cellini, C; Palumbo, A; Falco, P; Hájek, R; Boccadoro, M; Larocca, A.
Predictive value of beta2-microglobulin (beta2-m) levels in chronic lymphocytic leukemia since Binet A stages.
2009-01-01 Gentile, M; Cutrona, G; Neri, A; Molica, S; Ferrarini, M; Morabito, F.
Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
2002-01-01 Mauro, Fr; Gentile, M; Mancini, F; Giannarelli, D; Guarini, A; De Propriis, Ms; Cerretti, R; Foa, R.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials | 1-gen-2023 | Gentile, Massimo; Vigna, Ernesto; Palmieri, Salvatore; Galli, Monica; Derudas, Daniele; Mina, Roberto; Pepa, Roberta Della; Zambello, Renato; Martino, Enrica Antonia; Bruzzese, Antonella; Mangiacavalli, Silvia; Zamagni, Elena; Califano, Catello; Musso, Maurizio; Conticello, Concetta; Cerchione, Claudio; Mele, Giuseppe; Di Renzo, Nicola; Offidani, Massimo; Tarantini, Giuseppe; Casaluci, Gloria Margiotta; Rago, Angela; Ria, Roberto; Uccello, Giuseppina; Barilà, Gregorio; Palumbo, Gaetano; Pompa, Alessandra; Vincelli, Donatella; Brunori, Marino; Accardi, Fabrizio; Amico, Valeria; Amendola, Angela; Fontana, Raffaele; Bongarzoni, Velia; Rossini, Bernardo; Cotzia, Emilia; Gozzetti, Alessandro; Rizzi, Rita; Sgherza, Nicola; Ferretti, Eleonora; Bertuglia, Giuseppe; Nappi, Davide; Petrucci, Maria Teresa; Di Raimondo, Francesco; Neri, Antonino; Morabito, Fortunato; Musto, Pellegrino | |
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials | 1-gen-2020 | Gentile, M; Specchia, G; Derudas, D; Galli, M; Botta, C; Rocco, S; Conticello, C; Califano, C; Giuliani, N; Mangiacavalli, S; Attingenti, E; Lombardo, A; Brunori, M; Rossi, E; Antonioli, E; Ria, R; Zambello, R; Di Renzo, N; Mele, G; Marcacci, G; Musto, P; Capalbo, S; Cascavilla, N; Cerchione, C; Belotti, A; Criscuolo, C; Uccello, G; Curci, P; Vigna, E; Fraticelli, V; Vincelli, D; Bonalumi, A; Siniscalchi, A; Stocchi, R; Martino, M; Ballanti, S; Gangemi, D; Gagliardi, A; Gamberi, B; Pompa, A; Recchia, Ag; Tripepi, G; Pitino, A; Frigeri, F; Consoli, U; Bringhen, S; Zamagni, E; Patriarca, F; De Stefano, V; Di Raimondo, F; Palmieri, S; Petrucci, Mt; Offidani, M; Boccadoro, M; Cavo, M; Morabito, F. | |
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. | 1-gen-2003 | Mauro, Fr; Zinzani, P; Zaja, F; Gentile, M; Vegna, Ml; Stefoni, V; Marin, L; Fanin, R; Baccarani, M; Tura, S; Mandelli, F. | |
Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients. | 1-gen-2002 | Mauro, Fr; Foa, R; Meloni, G; Gentile, M; Giammartini, E; Giannarelli, D; De Propris, Ms; Rapanotti, Mc; de Fabritiis, P; Mandelli, F. | |
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial | 1-gen-2019 | Bringhen, S; D'Agostino, M; Paris, L; Ballanti, S; Pescosta, N; Spada, S; Pezzatti, S; Grasso, M; Rota-Scalabrini, D; De Rosa, L; Pavone, V; Gazzera, G; Aquino, S; Poggiu, M; Santoro, A; Gentile, M; Baldini, L; Petrucci, Mt; Tosi, P; Marasca, R; Cellini, C; Palumbo, A; Falco, P; Hájek, R; Boccadoro, M; Larocca, A. | |
Predictive value of beta2-microglobulin (beta2-m) levels in chronic lymphocytic leukemia since Binet A stages. | 1-gen-2009 | Gentile, M; Cutrona, G; Neri, A; Molica, S; Ferrarini, M; Morabito, F. | |
Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone. | 1-gen-2002 | Mauro, Fr; Gentile, M; Mancini, F; Giannarelli, D; Guarini, A; De Propriis, Ms; Cerretti, R; Foa, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile